PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Orally administered bergamot can reduce total cholesterol and low-density lipoprotein cholesterol (LDL-C) [PMID:31057945, PMID:35988871].
BEO aromatherapy is considered safe and useful for reducing stress symptoms [PMID:27747942]. In a randomized crossover trial, BEO spray used before bedtime and upon awakening was evaluated for improving sleep quality and reducing stress, anxiety, and depression [PMID:37625623].
Inhalation of bergamot oil on pillows for two nights significantly reduced anxiety scores [PMID:38490827].
Combined aromatherapy with lavender and bergamot essential oils, with or without mindfulness-based therapy, was studied for effects on menopausal symptoms, sleep quality, and serum cortisol [PMID:40378898].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 29976894 (2018) — Biological Activities and Safety of Citrus spp. Essential Oils. · International journal of molecular sciences
- 2.PMID: 6397734 (1984) — Phytophotodermatitis. · Photo-dermatology
- 3.PMID: 35988871 (2022) — A network meta-analysis on the comparative effect of nutraceuticals on lipid profile in adults. · Pharmacological research
- 4.PMID: 39487959 (2025) — A Neural Circuit For Bergamot Essential Oil-Induced Anxiolytic Effects. · Advanced science (Weinheim, Baden-Wurttemberg, Germany)
- 5.PMID: 37820919 (2023) — Bergamot polysaccharides relieve DSS-induced ulcerative colitis via regulating the gut microbiota and metabolites.